Audit and ComplianceGMP and PharmaWelding DocumentationISO 3834 Quality Requirements: A Documentation Framework for Pharma Welding

ISO 3834 has three tiers. Choosing the wrong one — or letting someone else choose it for you without understanding the consequences — creates a documentation gap that only becomes visible during an audit. In GMP-regulated manufacturing, that gap is almost always a serious finding.

The standard covers welding quality requirements for fusion welding of metallic materials. Part 2 defines comprehensive requirements, Part 3 defines standard requirements, and Part 4 defines elementary requirements. Each tier carries a different documentation burden, and the tier specified in a contract or by a regulatory framework is not negotiable once work begins.

What each tier actually requires

Part 4 (elementary) covers the minimum: a record that welding was performed, by whom, using what consumables. It suits structural applications where the consequence of a weld failure is manageable and traceability requirements are low.

Part 3 (standard) adds welding procedure specifications, welder qualification records, and post-weld inspection documentation. It is appropriate for many industrial applications and represents the baseline most manufacturers are familiar with.

Part 2 (comprehensive) goes considerably further. It requires pre-production planning documentation, heat treatment records, dimensional and visual inspection results tied to each weld, full material traceability through the supply chain, welder qualification with scope verification against the specific work performed, and records retention at a level that supports independent third-party review. It also requires that all of this documentation be organized so an auditor can reconstruct the production history of any weld without gaps.

Why GMP environments almost always require Part 2

Pharmaceutical and biotech manufacturing facilities are built under validation frameworks — IQ, OQ, PQ — that assume every step of construction and qualification is documented to a standard that permits independent verification. ISO 3834 Part 2 aligns with this assumption. Parts 3 and 4 do not.

Regulatory frameworks including FDA 21 CFR Part 11, EHEDG guidelines, and ASME BPE specifications all contain documentation requirements that map directly to Part 2. ASME BPE in particular, which governs high-purity systems in pharmaceutical processing, explicitly assumes Part 2-level traceability for weld records. When a pharma manufacturer certifies compliance with BPE, the underlying welding documentation needs to support that claim — and Part 3 documentation typically cannot.

This creates a practical problem. Many construction contractors default to Part 3 unless the contract explicitly specifies otherwise. By the time the facility owner discovers the documentation level during a pre-approval inspection, the welding is complete. Remediation at that stage is either impossible or extremely expensive.

What Part 2 requires that lower tiers do not

The practical differences between Part 2 and Part 3 come down to several specific requirements that have direct audit implications.

Pre-production planning: Part 2 requires that welding procedures, welder assignments, and inspection plans be documented before work begins, not after. This creates a record that the correct procedure was planned for each joint — not just that a procedure existed.

Welder qualification scope verification: Part 2 requires that each welder’s qualification is verified against the specific parameters of the work being performed — material group, thickness range, position, process. Part 3 requires qualification records but does not mandate this verification step at point of assignment.

Material traceability: Part 2 requires traceability from base material through heat number to the specific weld location. This means welding record logs must link to material test certificates at the joint level, not just at the project level. For systems that touch product in pharmaceutical manufacturing, this level of traceability is often non-negotiable.

Post-weld documentation: Part 2 requires that inspection results — visual, dimensional, and where applicable NDT — are recorded per weld and retained as part of the weld data book. Part 3 requires inspection but the documentation standard for results is less prescriptive.

The tier selection is a strategic decision

The choice of ISO 3834 tier should be made at the project specification stage, by someone who understands both the regulatory requirements and the documentation burden that each tier creates. In practice, it is often made by procurement teams focused on construction cost, who select contractors without specifying the required tier, or by contractors who default to Part 3 when Part 2 is not explicitly required.

For GMP facilities, the correct approach is to specify Part 2 in every construction contract that involves process piping, vessels, or equipment that will contact pharmaceutical product. This should be done regardless of what the contractor proposes, and it should be verified before work begins — not reviewed at closeout.

Digital welding documentation systems designed for GMP environments are built around Part 2 requirements by default. They capture pre-production planning records, link welders to qualifications at the point of assignment, maintain heat number traceability through the weld log, and produce data books organized for regulatory review. Managing Part 2 documentation manually at scale is where most of the audit findings originate — not because companies lack the records, but because the records exist in formats that cannot be retrieved and cross-referenced efficiently under inspection conditions.

For pharma and biotech projects, understanding the documentation requirements of ISO 3834 Part 2 before construction begins is the practical foundation of approval readiness. More on what GMP-specific welding documentation covers is available on the pharma and biotech documentation page.

Frequently asked questions

Can a facility certified to ISO 3834 Part 3 pass a GMP audit?

It depends on the specific regulatory requirements and the contract. In most pharmaceutical manufacturing environments that follow ASME BPE or FDA validation expectations, Part 3 documentation will fall short on traceability and pre-production planning requirements. Part 2 is the standard baseline for these environments.

Who is responsible for specifying the ISO 3834 tier?

The facility owner or project owner, typically through the engineering specification or ITT documents. Contractors fulfill the requirement; they do not set it. If the tier is not specified, contractors will apply their own standard, which is often Part 3.

Is ISO 3834 Part 2 mandatory for all pharmaceutical welding?

Not formally mandatory in all markets, but it is the industry standard expectation for product-contact systems in regulated pharmaceutical manufacturing. Many quality agreements and authority inspection protocols assume Part 2 compliance, even when it is not cited explicitly in the regulation.

What is the difference between ISO 3834 and ASME BPE in practice?

ASME BPE governs design, materials, and finish requirements for high-purity bioprocessing equipment. ISO 3834 governs welding quality management — the procedures, qualifications, and documentation around how welds are made and verified. In a BPE-compliant facility, both frameworks apply to the welding work. They address different aspects and are not alternatives to each other.